GLP-1 Medications and Hair Loss: What the New Research Actually Tells Us

(last updated July 2026)

You may have seen headlines this week linking a group of weight loss and diabetes medications known as GLP-1 receptor agonists to hair loss. The story comes from a large new study published in The BMJ, and as always with health headlines, the details matter more than the headline. Here's what the study found, what it means in practical terms, and what to do if you're noticing changes in your own hair.

Researchers at the University of Pennsylvania analysed the health records of more than 27,000 adults with type 2 diabetes between 2019 and 2024. They compared people who started a GLP-1 receptor agonist with people who started one of two other classes of diabetes medication (SGLT-2 inhibitors and DPP-4 inhibitors), and then tracked how often a new diagnosis of hair loss (alopecia) appeared in their records.

After adjusting for factors such as age, sex, weight and other health conditions, people taking a GLP-1 medication were around 37% to 68% more likely to be diagnosed with hair loss than people taking the comparison diabetes drugs. The association was specific to non-scarring hair loss, the kind where the hair follicles remain healthy and hair can regrow.

This is the most important part of the story, and the part headlines tend to skip.

A percentage increase in risk (the relative risk) only means something once you know how common the problem is in the first place (the absolute risk). In this study, hair loss was uncommon in every group:

• Among GLP-1 users, roughly 7 people in every 1,000 were diagnosed with hair loss per year of treatment.
• Among users of the comparison drugs, it was roughly 4 to 5 people in every 1,000 per year.

So in real-world terms, the study suggests that taking a GLP-1 medication for a year might mean around 2 to 3 extra cases of hair loss for every 1,000 people treated. Put another way, more than 99% of people in the study did not develop diagnosed hair loss in a given year, whichever medication they took. An increased risk does not make something common, and this remains an uncommon side effect.

It's also worth knowing that this was an observational study. It's a well-designed one, but studies of this type show associations rather than proving cause and effect, and the researchers themselves note that other unmeasured factors could have influenced the results.

Interestingly, it may not be the drug itself. Rapid weight loss, from any cause, including diet, surgery or medication, is a well-recognised trigger for a temporary type of hair shedding called telogen effluvium. When the body loses weight quickly, a larger proportion of hair follicles than usual shift into their "resting" phase and shed a few months later. Rapid weight loss can also contribute to low iron or zinc levels, which affect the hair growth cycle. Hormonal shifts may play a role too.

The reassuring feature is that this type of hair loss is generally temporary and reversible. The follicles are not damaged, and hair typically regrows once weight stabilises and any nutritional gaps are corrected.

Everyone in this study had type 2 diabetes, and the comparison groups were taking other diabetes medications. That's a different population from people using GLP-1 medications purely for weight management. People with diabetes have different background health risks, and diabetes itself, along with some of its treatments, can influence hair and skin. So while the findings are relevant and worth knowing about, the exact numbers may not translate directly to people without diabetes using these medications for weight loss. More research in non-diabetic populations is needed.

If you're taking a GLP-1 medication and notice hair thinning, it's tempting to assume the medication is the culprit. But hair loss is common in the general population and has many possible causes, which is exactly why it's worth seeing your GP rather than self-diagnosing. Things your doctor will typically consider include:

• Iron deficiency: one of the most common and treatable causes, especially in women
• Thyroid problems: both an underactive and overactive thyroid can cause hair changes
• Nutritional factors: including zinc, vitamin D and inadequate protein intake, particularly relevant when appetite is reduced on these medications
• Hormonal changes: such as menopause, polycystic ovary syndrome, or the months after pregnancy
• Pattern (androgenetic) hair loss: the gradual, hereditary thinning that affects a large proportion of both men and women with age
• Recent physical or emotional stress: major illness, surgery, or significant life stress can trigger shedding two to three months later
• Other medications: a number of common medicines can contribute
• Scalp and autoimmune conditions: such as alopecia areata or scalp skin disorders

A simple consultation, examination and a few blood tests can identify or rule out most of these. Correcting something like low iron or a thyroid issue will do far more for your hair than stopping an effective medication ever would.

1. Don't stop your medication on your own. These medications are usually prescribed for good reasons, and stopping suddenly can undo hard-won progress with weight, blood sugar and overall health. Any change should be a shared decision with your doctor.
2. Arrange a review with your GP or prescribing doctor. They can check for the common, treatable causes above, look at how quickly you're losing weight, and review your protein and nutrient intake.
3. Slow and steady may help. If rapid weight loss appears to be the trigger, adjusting the dose or the pace of weight loss, and making sure protein, iron and zinc intake are adequate, is often enough.
4. Give it time. Shedding related to weight loss typically settles within several months as the body adjusts, with regrowth to follow.
5. Ask about a dermatologist referral if things don't improve. If we've addressed the common causes, and a medication adjustment or change hasn't helped, a referral to a dermatologist is a sensible next step. Dermatologists can examine the scalp in detail, perform additional tests where needed, and offer specific treatments for persistent hair loss.

This new research adds useful, systematic evidence to what were previously only anecdotal reports: GLP-1 medications appear to be associated with a modestly increased risk of hair loss, most likely driven by rapid weight loss rather than a toxic effect on hair follicles. The absolute risk remains low, the type of hair loss involved is generally reversible, and the study was conducted in people with type 2 diabetes, so the findings may not apply exactly to everyone using these medications.

For most people, the substantial benefits of these medications, for weight, blood sugar, heart health and more, will continue to outweigh this small risk. But if you notice hair changes, it is worth raising them with your doctor rather than guessing at the cause. In many cases, the cause is treatable or temporary, and a review can help identify what is going on.

Source: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation. The BMJ, July 2026. This article is general information only and is not a substitute for personalised medical advice. Please speak with your doctor about your individual circumstances.